Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit
about
Methylselenol formed by spontaneous methylation of selenide is a superior selenium substrate to the thioredoxin and glutaredoxin systemsMethylseleninic acid enhances paclitaxel efficacy for the treatment of triple-negative breast cancerMethylseleninic acid restricts tumor growth in nude mice model of metastatic breast cancer probably via inhibiting angiopoietin-2Methylseleninic acid sensitizes Notch3-activated OVCA429 ovarian cancer cells to carboplatinSelenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.Selenomethionine and alpha-tocopherol do not inhibit prostate carcinogenesis in the testosterone plus estradiol-treated NBL rat model.Tumor inhibition by sodium selenite is associated with activation of c-Jun NH2-terminal kinase 1 and suppression of beta-catenin signaling.Lobe-specific proteome changes in the dorsal-lateral and ventral prostate of TRAMP mice versus wild-type miceTelomerase as an important target of androgen signaling blockade for prostate cancer treatment.L-selenomethionine does not protect against testosterone plus 17β-estradiol-induced oxidative stress and preneoplastic lesions in the prostate of NBL ratsFunctional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein.Selenium and prostate cancer prevention: insights from the selenium and vitamin E cancer prevention trial (SELECT).Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status.XAS studies of Se speciation in selenite-fed rats.Enhanced apoptotic effects by the combination of curcumin and methylseleninic acid: potential role of Mcl-1 and FAK.Methylselenol prodrug enhances MDV3100 efficacy for treatment of castration-resistant prostate cancerGalbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.Soy content of basal diets determines the effects of supplemental selenium in male miceMethylselenocysteine preventing castration-resistant progression of prostate cancerEncapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention.A Perspective on Prostate Carcinogenesis and ChemopreventionMethylseleninic acid activates Keap1/Nrf2 pathway via up-regulating miR-200a in human oesophageal squamous cell carcinoma cells.Combination effects of dietary soy and methylselenocysteine in a mouse model of prostate cancer.Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate CarcinogenesisA high-fat diet containing whole walnuts (Juglans regia) reduces tumour size and growth along with plasma insulin-like growth factor 1 in the transgenic adenocarcinoma of the mouse prostate model.Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.Growth and Progression of TRAMP Prostate Tumors in Relationship to Diet and ObesityInhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth.Does a role for selenium in DNA damage repair explain apparent controversies in its use in chemoprevention?Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges.Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study.Chemopreventive effect of Korean Angelica root extract on TRAMP carcinogenesis and integrative "omic" profiling of affected neuroendocrine carcinomas.Selenium for the prevention of cutaneous melanoma.Co-targeting hexokinase 2-mediated Warburg effect and ULK1-dependent autophagy suppresses tumor growth of PTEN- and TP53-deficiency-driven castration-resistant prostate cancer.Modeling prostate cancer in mice: limitations and opportunitiesA novel sulindac derivative lacking cyclooxygenase-inhibitory activities suppresses carcinogenesis in the transgenic adenocarcinoma of mouse prostate model.Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate modelMethylseleninic acid elevates REDD1 and inhibits prostate cancer cell growth despite AKT activation and mTOR dysregulation in hypoxia.Regulation of NF-E2-related factor 2 signaling for cancer chemoprevention: antioxidant coupled with antiinflammatory.Which form is that? The importance of selenium speciation and metabolism in the prevention and treatment of disease.
P2860
Q21090837-1CD0EBB6-256D-46F6-BBE1-4BAD61B6E541Q21134780-C9C973E2-1DB7-4347-BF1B-AE8B1F66D5BFQ21261285-FA960E0B-C1B7-4234-BBEF-6AF5D8270457Q28540634-F76D826A-C0C4-4A0D-860E-30D427715CDBQ33573583-E44CCE09-2A19-4E1E-A570-3A6EB6A74E2CQ33708061-289C3D8F-A36F-415D-8407-75A699801125Q33823652-128FA950-792B-46B8-AA9E-7B7E806A34A0Q33906861-C8EF4427-47B6-4FC9-9DA8-542F28E1051DQ33981807-9EAB7BE1-55FF-4658-8B09-D76182A3896DQ34025688-12273688-7EBD-4CF1-8FE6-0D4088385187Q34042351-B16CCA73-4A28-4813-AFF5-58E2F6C6CCC0Q34336747-5D46CA0D-A71C-4122-9DDE-0354B89B3049Q34500651-89819F14-77C9-4DA0-B6A4-562E0841BB0AQ34573982-A9D798BC-00F2-4323-AD90-DA5F099E8860Q34639407-C2A795B5-D9BD-4618-9830-E03D7ABF086EQ34663140-CCB9EA19-78A3-4571-B93C-D6CD2B17D7C3Q35109795-FC0DEB4D-D2A0-4630-9841-8D3B407F8F49Q35572551-6F1A404E-18B7-44CF-951E-C6741825A7C5Q35582612-A8B93A08-1300-4566-A23C-A57B234B4F03Q35972532-8F9C0CFE-DF9D-4387-84EC-3EE1427E02D1Q36116269-64980C72-88F1-4E47-8CFF-8A54567BB8FBQ36185212-F17B62C7-2210-4C0D-94C7-E9AE3AAD1FFDQ36238826-C7712004-C7A3-4226-8597-8D98F697BCF8Q36288473-0874708D-33F7-4FEA-AF98-680B40F08884Q36443123-7B96507F-E161-426B-A0DC-F6D14FF35A1BQ36446645-168FFF07-F3D3-4C6A-B931-525B03DA1B33Q36469104-27FDFCD4-BD02-4D2A-A16B-9CBE5DD250ECQ36584173-7A1F31A8-9C4F-43CC-9574-037C371CB057Q36605533-0213CFEA-F24F-4533-AA08-CF059DBAF165Q36769227-2C7EE772-44E8-4498-8725-C979C7472F37Q36833801-1C8CECC8-8E40-46A4-9691-E56EBC589601Q36915415-8D2A4C13-0263-419D-A8B5-909F6396A47AQ36993984-83243F3C-E11E-40EC-8661-3621667401ADQ37008469-761121A1-BBA9-45BE-AFC9-E5929E6D53D4Q37053034-13D7ED5A-371F-427F-ADC7-6E9DA78634EDQ37188714-65A0226A-E3E1-4B0D-9CAA-6D4E786B9CE9Q37365555-E4EB0941-212C-47FA-BD39-E293E445D5D9Q37703369-D55DFF7D-22D3-4A1E-9689-3AC6FE279A37Q37756926-D2029319-CFFC-4609-B5B0-26509F7679E6Q38137010-AB36B903-C124-4967-84C3-6260F1688E5E
P2860
Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Methyl-selenium compounds inhi ...... te model with survival benefit
@ast
Methyl-selenium compounds inhi ...... te model with survival benefit
@en
type
label
Methyl-selenium compounds inhi ...... te model with survival benefit
@ast
Methyl-selenium compounds inhi ...... te model with survival benefit
@en
prefLabel
Methyl-selenium compounds inhi ...... te model with survival benefit
@ast
Methyl-selenium compounds inhi ...... te model with survival benefit
@en
P2093
P2860
P1476
Methyl-selenium compounds inhi ...... te model with survival benefit
@en
P2093
Guang-xun Li
Hyo-Jeong Lee
Joshua D Liao
Junxuan Lü
Margot P Cleary
Melissa J L Bonorden
Yong Zhang
P2860
P304
P356
10.1158/1940-6207.CAPR-08-0173
P577
2009-04-28T00:00:00Z